| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06616987 | Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic… | Breast Cancer Metastatic | Recruiting |
| NCT06849947 | Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After… | Breast Cancer Metastatic | Not Yet Recruiting |
| Not specified | |||
| NCT07132749 | NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd | Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd | Enrolling by Invitation |